Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 2/20 | 0.41 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.39 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.39 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.39 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.35 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.35 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.35 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.35 |
| ▸ | EYA2 | O00167 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxalic Acid SCHEMBL216302 | 1.00 | FFAR3 (0.41) | FFAR3CHRM2CHRM4CHRM5CHRM1 | |
| Oxalic Acid SCHEMBL27532528 | 1.00 | FFAR3 (0.41) | FFAR3CHRM2CHRM4CHRM5CHRM1 | |
| Oxalic Acid SCHEMBL28460363 | 0.97 | FFAR3 (0.39) | FFAR3CHRM2CHRM4CHRM5CHRM1 | |
| Oxalic Acid SCHEMBL27615093 | 0.97 | FFAR3 (0.39) | FFAR3CHRM2CHRM4CHRM5CHRM1 | |
| Oxalic Acid SCHEMBL19209492 | 0.91 | ARG1 (0.35) | FFAR3CHRM2CHRM4CHRM5CHRM1 | |
| Oxalic Acid SCHEMBL19209502 | 0.91 | ARG1 (0.35) | FFAR3CHRM2CHRM4CHRM5CHRM1 | |
| Bicarbonate SCHEMBL378701 | 0.89 | FFAR3 (0.44) | FFAR3CHRM2CHRM4CHRM5CHRM1 | |
| Bicarbonate SCHEMBL60768 | 0.89 | FFAR3 (0.44) | FFAR3CHRM2CHRM4CHRM5CHRM1 | |
| Pyruvate SCHEMBL21145028 | 0.87 | CHRM2 (0.41) | FFAR3CHRM2CHRM4CHRM5CHRM1 | |
| Oxalic Acid SCHEMBL28576882 | 0.87 | TDP1 (0.43) | FFAR3CHRM2CHRM4CHRM5CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025132334-A1 | RESISTS USING PFAS FREE PAGS | MERCK PATENT GMBH (DE) | 2025-06-26 | — | — | WO | disclosed |
| WO-2025075046-A1 | ANALYSIS METHOD | 株式会社ダイセル | 2025-04-10 | — | — | WO | disclosed |
| US-20200179254-A1 | IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION | HENKEL AG & CO. KGAA (DE) | 2020-06-11 | — | — | US | disclosed |
| US-20190240129-A1 | CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION | HENKEL AG & CO. KGAA (DE) | 2019-08-08 | — | — | US | disclosed |
| EP-3518878-A1 | IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION | Henkel AG & Co. KGaA (DE) | 2019-08-07 | — | — | EP | disclosed |
| US-20190216714-A1 | IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION | HENKEL AG & CO. KGAA (DE) | 2019-07-18 | — | — | US | disclosed |
| US-20190216703-A1 | IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION | HENKEL AG & CO. KGAA (DE) | 2019-07-18 | — | — | US | disclosed |
| US-8425867-B2 | Oxalate sorbents for mercury removal | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2013-04-23 | — | — | US | disclosed |
| US-20130045149-A1 | OXALATE SORBENTS FOR MERCURY REMOVAL | Empire Technology Developement LLC | 2013-02-21 | — | — | US | disclosed |
| WO-2013025197-A1 | OXALATE SORBENTS FOR MERCURY REMOVAL | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2013-02-21 | — | — | WO | disclosed |
| EP-1861364-B1 | PREPARATION OF AN ATORVASTATIN INTERMEDIATE USING A PAAL-KNORR CONDENSATION | C P PHARMACEUTICALS INTERNAT C V (US) | 2011-05-11 | — | — | EP | disclosed |
| US-7128976-B2 | Composition for film formation, method of film formation, and silica-based film | JSR CORPORATION (JP) | 2006-10-31 | — | — | US | disclosed |
| US-20030091838-A1 | Composition for film formation, method of film formation, and silica-based film | JSR CORPORATION (JP) | 2003-05-15 | — | — | US | disclosed |
| US-5647116-A | Method for stripping non-superconductive AG-based sheath formed on a wire | NATIONAL SCIENCE COUNCIL (TW) | 1997-07-15 | — | — | US | disclosed |
| US-5103042-A | METHOD FOR REDUCING UNSATURATION OF POLYETHERS | THE DOW CHEMICAL COMPANY (US) | 1992-04-07 | — | — | US | disclosed |
| EP-0458262-A2 | Method for reducing unsaturation of polyethers | THE DOW CHEMICAL COMPANY (US) | 1991-11-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190240129-A1 | CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION | KRT18, CUTA, S100A10 | FFAR3 2270/4885CHRM2 1867/4885CHRM4 3102/4885 |
| US-20190216703-A1 | IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION | KRT18, SRRM2, IK | FFAR3 1837/4885CHRM2 1254/4885CHRM4 2814/4885 |
| US-20190216714-A1 | IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION | KRT18, CD44, PCNA | FFAR3 3218/4885CHRM2 1393/4885CHRM4 2434/4885 |
| US-20200179254-A1 | IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION | KRT18, CUTA, DSG1 | FFAR3 2914/4885CHRM2 1307/4885CHRM4 2288/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.